| Dr Nicholas Starkey, DO | |
|
804 Service Rd, D100, East Lansing, MI 48824-7015 | |
| (517) 353-5053 | |
| (517) 432-4394 |
| Full Name | Dr Nicholas Starkey |
|---|---|
| Gender | Male |
| Speciality | Diagnostic Radiology |
| Experience | 14 Years |
| Location | 804 Service Rd, East Lansing, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245542588 | NPI | - | NPPES |
| 1245542588 | Medicaid | MI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 5101018940 (Michigan) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Diagnostic Centers Of America, Llp | 0547174120 | 58 |
News Archive
Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced its new Thermo Scientific Smart-Vue wireless monitoring solution. Smart-Vue™ protects precious samples by monitoring key laboratory parameters including temperature, CO2 concentration, humidity and differential pressure. It can be installed by the user on most laboratory equipment, including ultra-low temperature freezers, laboratory refrigerators, CO2 incubators and clean rooms.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
New research highlights a more accurate way to screen for preeclampsia in pregnant women than currently recommended methods. Published early online in Ultrasound in Obstetrics & Gynecology, the study challenges the UK's current guidelines on the management of hypertensive disorders during pregnancy.
› Verified 9 days ago
| Entity Name | Radiology Associates Of South Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699759183 PECOS PAC ID: 5799689659 Enrollment ID: O20031121000573 |
News Archive
Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced its new Thermo Scientific Smart-Vue wireless monitoring solution. Smart-Vue™ protects precious samples by monitoring key laboratory parameters including temperature, CO2 concentration, humidity and differential pressure. It can be installed by the user on most laboratory equipment, including ultra-low temperature freezers, laboratory refrigerators, CO2 incubators and clean rooms.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
New research highlights a more accurate way to screen for preeclampsia in pregnant women than currently recommended methods. Published early online in Ultrasound in Obstetrics & Gynecology, the study challenges the UK's current guidelines on the management of hypertensive disorders during pregnancy.
› Verified 9 days ago
| Entity Name | Boca Radiology Group Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033163423 PECOS PAC ID: 2567354707 Enrollment ID: O20040325000185 |
News Archive
Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced its new Thermo Scientific Smart-Vue wireless monitoring solution. Smart-Vue™ protects precious samples by monitoring key laboratory parameters including temperature, CO2 concentration, humidity and differential pressure. It can be installed by the user on most laboratory equipment, including ultra-low temperature freezers, laboratory refrigerators, CO2 incubators and clean rooms.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
New research highlights a more accurate way to screen for preeclampsia in pregnant women than currently recommended methods. Published early online in Ultrasound in Obstetrics & Gynecology, the study challenges the UK's current guidelines on the management of hypertensive disorders during pregnancy.
› Verified 9 days ago
| Entity Name | Mori Bean And Brooks Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093782070 PECOS PAC ID: 8820077878 Enrollment ID: O20040714001317 |
News Archive
Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced its new Thermo Scientific Smart-Vue wireless monitoring solution. Smart-Vue™ protects precious samples by monitoring key laboratory parameters including temperature, CO2 concentration, humidity and differential pressure. It can be installed by the user on most laboratory equipment, including ultra-low temperature freezers, laboratory refrigerators, CO2 incubators and clean rooms.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
New research highlights a more accurate way to screen for preeclampsia in pregnant women than currently recommended methods. Published early online in Ultrasound in Obstetrics & Gynecology, the study challenges the UK's current guidelines on the management of hypertensive disorders during pregnancy.
› Verified 9 days ago
| Entity Name | Diagnostic Centers Of America, Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730125261 PECOS PAC ID: 0547174120 Enrollment ID: O20080223000067 |
News Archive
Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced its new Thermo Scientific Smart-Vue wireless monitoring solution. Smart-Vue™ protects precious samples by monitoring key laboratory parameters including temperature, CO2 concentration, humidity and differential pressure. It can be installed by the user on most laboratory equipment, including ultra-low temperature freezers, laboratory refrigerators, CO2 incubators and clean rooms.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
New research highlights a more accurate way to screen for preeclampsia in pregnant women than currently recommended methods. Published early online in Ultrasound in Obstetrics & Gynecology, the study challenges the UK's current guidelines on the management of hypertensive disorders during pregnancy.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nicholas Starkey, DO 804 Service Rd, A201, East Lansing, MI 48824-7015 Ph: (517) 884-2976 | Dr Nicholas Starkey, DO 804 Service Rd, D100, East Lansing, MI 48824-7015 Ph: (517) 353-5053 |
News Archive
Patients with prostate cancer who receive high-dose radiation treatment and also take statin drugs commonly used to lower cholesterol have a 10 percent higher chance of being cured of their cancer at 10 years after diagnosis (76 percent), compared to those who don't take these medications (66 percent), according to a study presented at a scientific session October 31, 2007, at the American Society for Therapeutic Radiology and Oncology's 49th Annual Meeting in Los Angeles.
A new study led by clinician-researchers at Beth Israel Deaconess Medical Center testing the safety and effectiveness of anticoagulant strategies for patients with atrial fibrillation who undergo stenting procedures has shown that therapies combining the anticoagulant drug rivaroxaban with either single or dual anti-platelet therapy were more effective in preventing bleeding complications than the current standard of care.
Thermo Fisher Scientific Inc., the world leader in serving science, today introduced its new Thermo Scientific Smart-Vue wireless monitoring solution. Smart-Vue™ protects precious samples by monitoring key laboratory parameters including temperature, CO2 concentration, humidity and differential pressure. It can be installed by the user on most laboratory equipment, including ultra-low temperature freezers, laboratory refrigerators, CO2 incubators and clean rooms.
Otoharmonics Corporation, announces that it has received a Class 2 medical device license from Health Canada for the Levo system, a personalized neuroscience-based sound therapy for use in the temporary relief of tinnitus symptoms.
New research highlights a more accurate way to screen for preeclampsia in pregnant women than currently recommended methods. Published early online in Ultrasound in Obstetrics & Gynecology, the study challenges the UK's current guidelines on the management of hypertensive disorders during pregnancy.
› Verified 9 days ago
Dr. Eric Joseph Biondo-savin, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 804 Service Rd, D100, East Lansing, MI 48824 Phone: 517-353-5053 Fax: 517-432-4394 | |
Thomas Loi, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 138 Service Rd Ste A204, East Lansing, MI 48824 Phone: 517-353-4920 Fax: 517-432-2243 | |
Robert Jarrett Steffy, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 846 Service Rd, East Lansing, MI 48824 Phone: 517-355-0120 | |
Dr. James Kevin Demarco, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 804 Service Road, Room 204, East Lansing, MI 48824 Phone: 517-353-4920 | |
Dr. David A Patrick, DO Radiology Medicare: Accepting Medicare Assignments Practice Location: 4660 S Hagadorn Rd Ste 410, East Lansing, MI 48823 Phone: 517-353-5053 Fax: 517-884-6236 | |
Dr. Julia Hobson, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 4660 S Hagadorn Rd Ste 410, East Lansing, MI 48823 Phone: 517-884-6123 Fax: 517-884-6236 |